Market Cap (In USD)
131.72 Million
Revenue (In USD)
18.92 Million
Net Income (In USD)
-52.44 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.0E-4-9.466
- PE
- -
- EPS
- -
- Beta Value
- 7.688
- ISIN
- AU0000282840
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. William Lay B.Com.
- Employee Count
- -
- Website
- https://www.cresopharma.com
- Ipo Date
- 2017-09-07
- Details
- Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
More Stocks
-
BREBBrederode SA
BREB
-
CDLCDRL S.A.
CDL
-
6857Acer Medical Inc.
6857
-
HMSOHammerson plc
HMSO
-
FIHO12FibraHotel
FIHO12
-
OAMCFOverActive Media Corp.
OAMCF
-
AMNIAmniotics AB (publ)
AMNI
-
VTXPFVictrex plc
VTXPF